The Bergand Group – May 2015 Newsletter
Basics of Managing the Dual Diagnosis Patient By Dr. Paul F. Giannandrea – Clinical Director – The Bergand Group Patients with both a psychiatric diagnosis and chemical dependence are common in the treatment population at the Bergand Group. In general, 47% of schizophrenics, 32 % of mood disordered and 60% of bipolar disordered patients abuse
The Bergand Group – May 2015 Newsletter Read More »